Literature DB >> 22076501

Epicatechin inhibits human plasma lipid peroxidation caused by haloperidol in vitro.

Anna Dietrich-Muszalska1, Bogdan Kontek, Beata Olas, Jolanta Rabe-Jabłońska.   

Abstract

Epicatechin belongs to flavonoids protecting cells against oxidative/nitrative stress. Oxidative/nitrative stress observed in schizophrenia may be caused partially by the treatment of patients with various antipsychotics. The aim of our study was to establish the effects of epicatechin and antipsychotics action (the first generation antipsychotic (FGA)--haloperidol and the second generation antipsychotic (SGA)--amisulpride) on peroxidation of plasma lipids in vitro. Lipid peroxidation in human plasma was measured by the level of thiobarbituric acid reactive species (TBARS). The properties of epicatechin were also compared with the action of a well characterized antioxidative commercial polyphenol-resveratrol (3,4',5-trihydroxystilbene) and quercetin (3,5,7,3',4'-pentahydroxyflavone). Amisulpride, contrary to haloperidol (after 1 and 24 h) does not significantly influence the increase of plasma TBARS level in comparison with control samples (P > 0.05). After incubation (1 and 24 h) of plasma with haloperidol in the presence of epicatechin we observed a significantly decreases the level of TBARS (P < 0.001, P < 0.001, respectively). In our other experiments, we found that epicatechin also decreased the amount of TBARS in human plasma treated with amisulpride. In conclusion, the presented results indicate that epicatechin-the major polyphenolic component of green tea reduced significantly human plasma lipid peroxidation caused by haloperidol. Moreover, epicatechin was found to be a more effective antioxidant, than the solution of pure resveratrol or quercetin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22076501     DOI: 10.1007/s11064-011-0642-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

1.  Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study.

Authors:  Hui-chun Li; Qiao-zhen Chen; Ying Ma; Jun-fu Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

2.  Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.

Authors:  J B Lohr; R Kuczenski; H S Bracha; M Moir; D V Jeste
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

3.  Effects of epigallocatechin gallate, L-ascorbic acid, alpha-tocopherol, and dihydrolipoic acid on the formation of deoxyguanosine adducts derived from lipid peroxidation.

Authors:  Raghu G Nath; Mona Y Wu; Armaghan Emami; Fung-Lung Chung
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

4.  (-)-Epicatechin inhibits nitration and dimerization of tyrosine in hydrophilic as well as hydrophobic environments.

Authors:  P Schroeder; H Zhang; L O Klotz; B Kalyanaraman; H Sies
Journal:  Biochem Biophys Res Commun       Date:  2001-12-21       Impact factor: 3.575

5.  Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients.

Authors:  N Srivastava; M K Barthwal; P K Dalal; A K Agarwal; D Nag; R C Srimal; P K Seth; M Dikshit
Journal:  Psychopharmacology (Berl)       Date:  2001-11       Impact factor: 4.530

6.  Oxidative stress in blood platelets from schizophrenic patients.

Authors:  A Dietrich-Muszalska; B Olas; J Rabe-Jablonska
Journal:  Platelets       Date:  2005-11       Impact factor: 3.862

7.  Modifications of blood platelet proteins of patients with schizophrenia.

Authors:  Anna Dietrich-Muszalska; Beata Olas
Journal:  Platelets       Date:  2009-03       Impact factor: 3.862

8.  Induction of reactive oxygen species in neurons by haloperidol.

Authors:  Y Sagara
Journal:  J Neurochem       Date:  1998-09       Impact factor: 5.372

9.  Plasma amisulpride levels in schizophrenia or schizoaffective disorder.

Authors:  N Bergemann; J Kopitz; K R Kress; A Frick
Journal:  Eur Neuropsychopharmacol       Date:  2004-05       Impact factor: 4.600

10.  Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics.

Authors:  Ganesh Dakhale; Suchet Khanzode; Shruti Khanzode; Anand Saoji; Linesh Khobragade; Avinash Turankar
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

View more
  2 in total

Review 1.  Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?

Authors:  Jana Trebatická; Zdeňka Ďuračková
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

Review 2.  Modulation of Gut Microbial Diversity through Non-Pharmaceutical Approaches to Treat Schizophrenia.

Authors:  Nayla Munawar; Aftab Ahmad; Munir Ahmad Anwar; Khalid Muhammad
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.